Camad, Saria A.

HRN: 09-85-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/20/2024
06/27/2024
IV
500MG
Q8HR
AMOEBIASIS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: